0001998501-25-000003.txt : 20250902 0001998501-25-000003.hdr.sgml : 20250902 20250902163742 ACCESSION NUMBER: 0001998501-25-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250902 DATE AS OF CHANGE: 20250902 EFFECTIVENESS DATE: 20250902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncobiomix Inc. CENTRAL INDEX KEY: 0001998501 ORGANIZATION NAME: EIN: 922126019 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-496565 FILM NUMBER: 251286110 BUSINESS ADDRESS: STREET 1: 8703 LEDGE RUN CITY: SAN ANTONIO STATE: TX ZIP: 78255 BUSINESS PHONE: 210-305-6513 MAIL ADDRESS: STREET 1: 8703 LEDGE RUN CITY: SAN ANTONIO STATE: TX ZIP: 78255 D/A 1 primary_doc.xml X0708 D/A LIVE 0001998501 Oncobiomix Inc. 3463 Magic Drive Suite T7 San Antonio TX TEXAS 78229 210-305-6513 DELAWARE None None Corporation true 2023 Michael Andre Liss 3463 Magic Drive, Suite T7 San Antonio TX TEXAS 78229 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001998501-25-000002 2023-10-26 false true Convertible Debt false 0 1000000 500000 500000 false 12 0 0 0 A portion of the proceeds will be used to pay compensation to some of the Executive Officers named in response to item 3 above. false Oncobiomix Inc. Michael Liss Michael A. Liss, M.D., Ph.D. President 2025-09-02